Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 3;17(10):e0275518.
doi: 10.1371/journal.pone.0275518. eCollection 2022.

Subjective and psychophysical olfactory and gustatory dysfunction among COVID-19 outpatients; short- and long-term results

Mads Mose Jensen  1 , Kasper Daugaard Larsen  1   2 , Anne-Sophie Homøe  1   3 , Anders Lykkemark Simonsen  4 , Elisabeth Arndal  2 , Anders Koch  4   5 , Grethe Badsberg Samuelsen  3 , Xiaohui Chen Nielsen  6 , Tobias Todsen  1   2   7 , Preben Homøe  1   7
Affiliations

Subjective and psychophysical olfactory and gustatory dysfunction among COVID-19 outpatients; short- and long-term results

Mads Mose Jensen et al. PLoS One. .

Erratum in

Abstract

Background: Olfactory and gustatory dysfunctions are early symptoms of SARS-CoV-2 infection. Between 20-80% of infected individuals report subjective altered sense of smell and/or taste during infection. Up to 2/3 of previously infected experience persistent olfactory and/or gustatory dysfunction after 6 months. The aim of this study was to examine subjective and psychophysical olfactory and gustatory function in non-hospitalized individuals with acute COVID-19 up to 6 months after infection.

Methods: Individuals aged 18-80-years with a positive SARS-CoV-2 PCR test no older than 10 days, were eligible. Only individuals able to visit the outpatient examination facilities were included. Gustatory function was tested with the Burgharts Taste Strips and olfactory function was examined with the Brief Smell Identifications test (Danish version). Subjective symptoms were examined through an online questionnaire at inclusion, day 30, 90 and 180 after inclusion.

Results: Fifty-eight SARS-CoV-2 positive and 56 negative controls were included. 58.6% (34/58) of SARS-CoV-2 positive individuals vs. 8.9% (5/56) of negative controls reported subjective olfactory dysfunction at inclusion. For gustatory dysfunction, 46.5% (27/58) of positive individuals reported impairment compared to 8.9% (5/56) of negative controls. In psychophysical tests, 75.9% (46/58) had olfactory dysfunction and 43.1% (25/58) had gustatory dysfunction among the SARS-CoV-2 positive individuals at inclusion. Compared to negative controls, SARS-CoV-2 infected had significantly reduced olfaction and gustation. Previously infected individuals continued to report lower subjective sense of smell 30 days after inclusion, whereafter the difference between the groups diminished. However, after 180 days, 20.7% (12/58) positive individuals still reported reduced sense of smell and taste.

Conclusion: Olfactory and gustatory dysfunctions are prevalent symptoms of SARS-CoV-2 infection, but there is inconsistency between subjective reporting and psychophysical test assessment of especially olfaction. Most individuals regain normal function after 30 days, but approximately 20% report persistent olfactory and gustatory dysfunction 6 months after infection.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Subjective smell scores at inclusion, day 30, 90 and 180.
Subjective smell score at inclusion, 30, 90 and 180 days after inclusion, stratified by SARS-CoV-2 status. Numeric Rank Scale where 0 is anosmia and 10 is normal sense of smell.
Fig 2
Fig 2. Subjective taste scores at inclusion, day 30, 90 and 180.
Subjective taste score at inclusion, 30, 90 and 180 after inclusion, stratified by SARS-CoV-2 status. Numeric Rank Scale where 0 is anosmia and 10 is normal sense of taste.
See this image and copyright information in PMC

References

    1. Sedaghat AR, Gengler I, Speth MM. Olfactory Dysfunction: A Highly Prevalent Symptom of COVID-19 With Public Health Significance. Otolaryngol—Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg 2020;163:12–5. doi: 10.1177/0194599820926464 - DOI - PubMed
    1. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol—Head Neck Surg 2020;277:2251–61. doi: 10.1007/s00405-020-05965-1 - DOI - PMC - PubMed
    1. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683–90. doi: 10.1001/jamaneurol.2020.1127 - DOI - PMC - PubMed
    1. Saniasiaya J, Islam MA, Abdullah B. Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients. The Laryngoscope 2021;131:865–78. doi: 10.1002/lary.29286 - DOI - PMC - PubMed
    1. Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis. Otolaryngol Neck Surg 2020;163:3–11. 10.1177/0194599820926473. - DOI - PubMed

Publication types